These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8735634

  • 1. Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
    Gardiner SM, March JE, Kemp PA, Bennett T.
    Br J Pharmacol; 1996 May; 118(2):325-34. PubMed ID: 8735634
    [Abstract] [Full Text] [Related]

  • 2. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T.
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [Abstract] [Full Text] [Related]

  • 3. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1996 Aug; 118(7):1822-8. PubMed ID: 8842449
    [Abstract] [Full Text] [Related]

  • 4. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [Abstract] [Full Text] [Related]

  • 5. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
    [Abstract] [Full Text] [Related]

  • 6. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
    Gardiner SM, Rakhit T, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
    [Abstract] [Full Text] [Related]

  • 7. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
    Gardiner SM, Compton AM, Kemp PA, Bennett T, Foulkes R, Hughes B.
    Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
    [Abstract] [Full Text] [Related]

  • 8. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
    Gardiner SM, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1998 Apr; 123(7):1403-8. PubMed ID: 9579736
    [Abstract] [Full Text] [Related]

  • 9. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW, Widdop RE.
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
    Widdop RE, Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1993 Mar; 108(3):684-8. PubMed ID: 8467356
    [Abstract] [Full Text] [Related]

  • 11. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM, Kemp PA, Brunner-Ferber F, Bennett T.
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [Abstract] [Full Text] [Related]

  • 12. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
    Batin P, Gardiner SM, Compton AM, Kemp PA, Bennett T.
    Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
    [Abstract] [Full Text] [Related]

  • 13. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1993 Sep; 110(1):159-62. PubMed ID: 8220876
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE, Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
    [Abstract] [Full Text] [Related]

  • 15. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM, Kemp PA, March JE, Woolley J, Bennett T.
    Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB, Bennett T, Randall MD, Gardiner SM.
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.